期刊
EXPERT REVIEW OF CARDIOVASCULAR THERAPY
卷 11, 期 9, 页码 1247-1257出版社
TAYLOR & FRANCIS INC
DOI: 10.1586/14779072.2013.832482
关键词
ampicillin; antibiotic resistance; ceftriaxone; enterococcus facalis; gentamicin; health care associated; infective endocarditis; mortality; relapse; treatment
资金
- Danish Heart Foundation
Enterococcus faecalis infective endocarditis (IE) is a disease of increasing importance, with more patients infected, increasing frequency of health-care associated infections and increasing incidence of antimicrobial resistances. The typical clinical presentation is a subacute course with fever, malaise and generalized aches, difficult to distinguish from other more common diseases. Of paramount importance is transthoracic-and transesophageal-echocardiography to establish the diagnosis. At the moment, the predominant strategies recommend ampicillin in combination with either gentamicin or ceftriaxone. E. faecalis infective endocarditis continues to be a very serious disease with considerable percentages of high-level gentamicin resistant strains and in-hospital mortality around 20%. Strategies to prevent E. faecalis IE, improve diagnostics, optimize treatment and reduce morbidity will be necessary to improve the overall prognosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据